All threads and posts regarding Coronavirus COVID-19 can now be found in our new area specifically for Coronavirus COVID-19 discussion.
You can directly access this area >here<.
I can see the advantages in tracking progression, but not in drugs trials. There would still have to be blind trials and regular screening, and as far as I know invasive tools are not used for screening -- at least ante mortem!He said: "The next step is to see whether we can use the technique to reliably track progression of the disease in a patient.
"This could prove a powerful and non-invasive tool for screening the efficacy of new drug treatments speedily, without a need for large costly clinical trials."